Analytical Instrumentation in Life Science Market Size & Research Report 2030

Name: Analytical Instrumentation in Life Science Market Size & Research Report 2030
Creator: Mordor Intelligence
License: https://www.mordorintelligence.com/privacy-policy

Analytical Instrumentation In Life Science Market Size and Share

Market Overview

Study Period	2019 - 2030
Market Size (2025)	USD 20.45 Billion
Market Size (2030)	USD 31.18 Billion
Growth Rate (2025 - 2030)	8.09% CAGR
Fastest Growing Market	Asia Pacific
Largest Market	North America
Market Concentration	Medium
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Analytical Instrumentation In Life Science Market (2025 - 2030) — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Analytical Instrumentation In Life Science Market Analysis by Mordor Intelligence

The analytical instrumentation in life science market size stood at USD 20.45 billion in 2025 and is forecast to reach USD 31.18 billion by 2030, reflecting an 8.09% CAGR. Heightened biologics development, stricter regulatory expectations for real-time process control, and accelerating precision-medicine programs are the primary engines behind this expansion.^{[1]FDA, “Content and Review of CMC Information for Human Somatic Cell Therapy INDs,” fda.gov} Growing demand for high-resolution mass spectrometry, chromatography innovations that support continuous manufacturing, and artificial-intelligence-powered data analytics continue to widen the application scope of next-generation instruments. Asia-Pacific records the fastest uptake as regional CDMOs standardize high-throughput screening, while North America capitalizes on its established R&D infrastructure to maintain value leadership.^{[2]ISPE, “Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact,” ispe.org} Competitive activity is typified by scale-building acquisitions that bundle instruments, software, and consumables into integrated workflow solutions.

Key Report Takeaways

By product type, chromatographs led with 29.8% revenue share in 2024, while spectrometers are tracking the highest 8.2% CAGR through 2030.
By end-user, the pharmaceutical segment held 60.1% of the analytical instrumentation in life science market share in 2024; biopharmaceutical and nutraceutical applications are advancing at a 9.1% CAGR.
By geography, North America commanded 39.4% revenue in 2024, whereas Asia-Pacific is projected to expand at a 9.5% CAGR to 2030.

Global Analytical Instrumentation In Life Science Market Trends and Insights

Drivers Impact Analysis

Driver	(~) % Impact on CAGR Forecast	Geographic Relevance	Impact Timeline
Surge in Demand of Analytical Instrumentation in Pharmaceutical Industry	+1.8%	Global, with concentration in North America & EU	Medium term (2-4 years)
Expansion of Cell and Gene Therapy Pipeline Necessitating High-Resolution Characterization	+1.5%	North America & EU core, expanding to APAC	Long term (≥ 4 years)
Regulatory Push for In-Line Process Analytical Technology (PAT) in Continuous Manufacturing	+1.2%	Global, led by FDA and EMA jurisdictions	Medium term (2-4 years)
Growing Public-Private Funding in Omics and Biomarker Research	+1.0%	North America & EU, emerging in APAC	Long term (≥ 4 years)
Rising Potency of Novel Drug Modalities Requiring Ultra-Sensitive Detection	+0.9%	Global, concentrated in major pharma hubs	Medium term (2-4 years)
Accelerated Adoption of High-Throughput Screening by Asian CDMOs	+0.7%	APAC core, spill-over to global supply chains	Short term (≤ 2 years)
Source: Mordor Intelligence

Surge in demand for analytical instrumentation in pharmaceutical manufacturing

The FDA’s 2025 update to 21 CFR 211.110 formalizes expectations for continuous processing, elevating process-analytical-technology (PAT) systems from optional enhancements to essential control tools. Harmonized ICH Q2(R2) and Q14 guidelines allow platform methods to be validated across multiple products, shrinking timelines and creating sustained pull for multi-attribute chromatography and mass-spectrometry solutions. Manufacturers now rely on real-time attribute measurements to release batches in hours rather than days, a shift that materially increases the installed base of high-performance instruments across development and commercial sites.

Expansion of cell and gene therapy pipeline

Regulators now highlight empty-capsid control and post-translational-modification monitoring as critical quality attributes for viral vectors, pushing biopharma firms toward orbitrap-class mass spectrometry and high-resolution chromatography.^{[3]BioProcess International, “Measure Twice, Treat Once: Assay Development in CGT,” bioprocessintl.com} Samsung Biologics reduced protein variant analysis from 6-8 weeks to 1-2 weeks by integrating LC-MS/MS with multiplexed workflows, demonstrating the productivity gains attached to next-generation platforms. As global gene-therapy trials multiply, demand for sensitive, high-throughput characterization tools cements spectrometers as pivotal growth engines in the analytical instrumentation in life science market.

Regulatory push for in-line PAT in continuous manufacturing

Quality-by-design paradigms require real-time parameter monitoring; magnetic-sector MS and Raman spectroscopy are being embedded into bioreactors and solvent-recovery loops to guide instantaneous feedback control. Europe’s PIC/S alignment is now mirrored by Singapore and South Korea, enabling vendors to deliver standardized PAT suites across multiple jurisdictions, accelerating global market penetration.

Growing public-private funding in omics and biomarker research

Thermo Fisher’s USD 3.1 billion Olink acquisition underscores the commercial weight of high-throughput proteomics in precision medicine. AI-driven Raman spectroscopy maps tumor-immune microenvironments with single-cell resolution, confirming how machine learning augments instrument value and widens clinical utility. Robust funding pipelines drive labs to invest in multiplexed mass-spectrometry and imaging platforms that accommodate integrated genomics–proteomics workflows, reinforcing long-term equipment outlays.^{[4]CACLP, “Thermo Fisher Scientific Reports Q1 2025 Results,” caclp.com}

Restraints Impact Analysis

Restraint	(~) % Impact on CAGR Forecast	Geographic Relevance	Impact Timeline
High Initial Cost	-1.4%	Global, particularly impacting emerging markets	Medium term (2-4 years)
Shortage of Skilled Analytical Chemists and Data Scientists	-1.1%	Global, acute in North America & EU	Long term (≥ 4 years)
Data Integrity and Validation Compliance Burden (ALCOA+ requirements)	-0.8%	Global, concentrated in regulated markets	Medium term (2-4 years)
Complex Preventive Maintenance Leading to Higher Downtime Costs	-0.6%	Global, affecting high-throughput facilities	Short term (≤ 2 years)
Source: Mordor Intelligence

High initial cost

Capital budgets remain tightly controlled; 64% of laboratories report difficulty approving new instrument purchases, and consumables can consume up to 80% of lifetime costs. Instrument-as-a-service models and shared-facility consortia are emerging to offset cash-flow barriers, while miniaturized handheld spectrometers projected to reach USD 4 billion by 2030 offer tailored, lower-priced alternatives for niche assays.^{[5]Spectroscopy Online, “Applications of Micro X-Ray Fluorescence Spectroscopy,” spectroscopyonline.com}

Shortage of skilled analytical chemists and data scientists

The fusion of AI with analytical workflows demands hybrid skills that remain scarce; universities underutilize advanced mass-spectrometry equipment, leaving graduates underprepared for industry roles. Median analytical-chemist salaries stalled at USD 105,000 in 2024, prompting talent migration toward higher-paying tech sectors and sustaining a structural labor deficit. Vendors are countering with intuitive software and remote-support platforms, yet complex data interpretation still requires expert oversight, prolonging the skills bottleneck.

Segment Analysis

By Type of Product: Spectrometers drive innovation beyond traditional boundaries

The spectrometer category contributed USD 7.1 billion to the analytical instrumentation in life science market size in 2025 and is set to grow at an 8.2% CAGR through 2030. Liquid chromatographs preserved a 67.4% slice of chromatography revenue, but ion chromatographs now register 8.4% growth on the back of trace-impurity testing mandates. Orbitrap Astral Zoom debuted in 2025 with 35% faster scan rates, enabling real-time peptide-mapping of complex biologics and cementing high-resolution MS as the preferred platform for cell-therapy analytics. Gas-chromatography vendors respond to helium shortages by integrating hydrogen-safety interlocks and nitrogen-switch kits, limiting carrier-gas costs for QC labs. Micro-XRF instruments gain traction for non-destructive elemental mapping in controlled-release tablet coatings, extending their reach beyond traditional materials science. Novel gas analyzers oriented toward bioprocess monitoring now post 9.3% annual growth, reflecting the shift toward continuous biomanufacturing workflows that rely on in-line CO₂ and O₂ analytics.

Second-generation spectrometers further reduce acquisition costs per data point, widening adoption in mid-tier firms without diluting analytical power. As instrument throughput rises, consumable vendors bundle ultralow-void columns and high-capacity trapping cartridges, creating a holistic ecosystem that enhances vendor lock-in. The analytical instrumentation in life science market therefore benefits from hardware, software, and reagent co-development that optimizes complete workflows rather than isolated instrument performance.

Analytical Instrumentation In Life Science Market: Market Share by Type of Product — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Get Detailed Market Forecasts at the Most Granular Levels

Download PDF

By End User Vertical: Biopharmaceuticals reshape analytical requirements

The pharmaceutical segment captured 60.1% revenue in 2024, but biopharmaceutical manufacturing is projected to outpace it, expanding at 9.1% CAGR and lifting the collective analytical instrumentation in life science market size for biologics to USD 12.9 billion by 2030. API producers still account for 63.7% of pharmaceutical purchases, yet outsourcing to contract development and manufacturing organizations (CDMOs) is accelerating at 10.2%, creating distributed demand across North American and Asian service hubs.

WuXi Biologics expanded Worcester capacity to 36,000 liters, underlining the scale of analytical demand embedded in multiproduct biologics sites. Samsung Biologics’ 784,000-liter campus exemplifies how mega-facilities integrate hundreds of chromatography, spectroscopy, and in-line PAT stations to maintain consistent viral-vector output. Nutraceutical producers increasingly adopt pharmaceutical-grade validation, leveraging mid-range LC-MS and FT-IR instruments for ingredient authentication and micro-contaminant surveillance. The convergence of end-user requirements encourages platform instrument designs that deliver compliance flexibility across a spectrum of therapeutic and wellness products.

Geography Analysis

North America retained 39.4% of 2024 revenue behind its advanced biomanufacturing infrastructure and earliest adoption of continuous-processing guidance. The region’s regulatory rigor drives consistent upgrades to high-resolution instruments, and domestic stimulus packages direct USD-scale investments toward on-shore manufacturing resilience.

Asia-Pacific is the fastest-growing territory, operating at a 9.5% CAGR to 2030 as CDMOs scale capacity and governments offer tax incentives for single-use bioreactors and PAT equipment. India’s generics sector and Singapore’s biologics corridor draw multinational firms that demand standardized QC platforms compatible with global filings, lifting the analytical instrumentation in life science market across the region. China’s CRO industry exceeded CNY 64.77 billion in 2023 and continues to import premium LC-MS and UHPLC systems to service complex molecule pipelines.

Europe holds steady growth as PIC/S alignment simplifies multinational instrument validation. Waters’ USD 45 million Longbridge plant triples local orbitrap component capacity, underscoring sustained European demand for precision manufacturing inputs. South America is an emerging buyer base; Shimadzu’s Mexico subsidiary seeks 150% sales growth by 2028, signalling regional appetite for tier-one instruments. Middle East and Africa remain early-stage but attract pilot-scale investments tied to vaccine self-sufficiency programs, foreshadowing incremental instrument shipments aligned to GMP facility buildouts.

Analytical Instrumentation In Life Science Market CAGR (%), Growth Rate by Region — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Get Analysis on Important Geographic Markets

Download PDF

Competitive Landscape

The analytical instrumentation in life science market is moderately consolidated; the top five suppliers control 49% of 2024 global revenue, with Thermo Fisher holding 23%. Multi-year acquisition pipelines aim to secure integrated software, consumables, and services that elevate switching costs. Thermo Fisher’s USD 4.1 billion purchase of Solventum’s purification unit extends its downstream-processing footprint and reinforces cross-selling of chromatography and filtration consumables. Agilent’s USD 925 million BioVectra buy-out strengthens the firm’s RNA-based therapeutics service offering, pairing sample-prep instrumentation with custom manufacturing capacity.

Waters, Danaher, and Bruker focus on differentiated high-resolution MS, GC-MS, and FT-IR systems, embedding AI-driven analytics to boost operator productivity. Waters’ BioResolve Protein A column achieves 7× sensitivity gains, underscoring how consumables innovation supports hardware competitiveness. Bruker integrates DART ionization for faster therapeutic-drug monitoring, broadening clinical applicability of its timsTOF platform. Medium-sized specialists leverage modular designs to serve niche workflows such as in-line gas analysis and mini-XRF food testing, cultivating defensible positions despite scale disadvantages.

Platform-level digital ecosystems emerge as the next battleground. Vendors that couple secure cloud data lakes with predictive-maintenance algorithms create visible ROI for labs facing skilled-labor shortages. Continuous expansion of subscription-based software revenue shields margin in an environment where instrument hardware is incrementally commoditizing.

Analytical Instrumentation In Life Science Industry Leaders

Agilent Technologies
Thermo Fisher Scientific
Waters Corporation
Bruker Corporation
Shimadzu Scientific
*Disclaimer: Major Players sorted in no particular order

Analytical Instrumentation In Life Science Market Concentration — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Need More Details on Market Players and Competitors?

Download PDF

Recent Industry Developments

June 2025: Thermo Fisher unveiled Orbitrap Astral Zoom and Orbitrap Excedion Pro, increasing scan speeds by 35% and multiplexing by 50%, targeting biopharma and omics workflows.
June 2025: Waters introduced BioResolve Protein A columns with MaxPeak Premier to boost antibody-titer sensitivity 7× and enable aggregate analyses.
June 2025: Bruker showcased DART integration and timsMetabo for PFAS detection, expanding routine clinical and environmental applications.
April 2025: Thermo Fisher committed USD 2 billion to U.S. innovation, allotting USD 500 million to R&D for next-generation analytical platforms.
April 2025: QIAGEN outlined three sample-prep instrument launches by 2026 to enhance lab automation and reduce plastic waste
February 2025: Thermo Fisher agreed to acquire Solventum’s purification and filtration business for USD 4.1 billion, aiming for mid-to-high single-digit organic growth.

Table of Contents for Analytical Instrumentation In Life Science Industry Report

1. INTRODUCTION

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

4.1 Market Overview
4.2 Market Drivers
- 4.2.1 Surge in Demand of Analytical Instrumentation in Pharmaceutical Industry
- 4.2.2 Expansion of Cell and Gene Therapy Pipeline Necessitating High-Resolution Characterization
- 4.2.3 Regulatory Push for In-Line Process Analytical Technology (PAT) in Continuous Manufacturing
- 4.2.4 Growing Public-Private Funding in Omics and Biomarker Research
- 4.2.5 Rising Potency of Novel Drug Modalities Requiring Ultra-Sensitive Detection
- 4.2.6 Accelerated Adoption of High-Throughput Screening by Asian CDMOs
4.3 Market Restraints
- 4.3.1 High Initial Cost
- 4.3.2 Shortage of Skilled Analytical Chemists and Data Scientists
- 4.3.3 Data Integrity and Validation Compliance Burden (ALCOA+ requirements)
- 4.3.4 Complex Preventive Maintenance Leading to Higher Downtime Costs
4.4 Industry Ecosystem Analysis
4.5 Technology Snapshot
- 4.5.1 Automation and Miniaturization in Analytical Instruments
- 4.5.2 AI/ML-assisted Spectral Interpretation
- 4.5.3 Multi-Omics Data Integration Platforms
4.6 Porter's Five Forces Analysis
- 4.6.1 Bargaining Power of Buyers/Consumers
- 4.6.2 Bargaining Power of Suppliers
- 4.6.3 Threat of New Entrants
- 4.6.4 Threat of Substitute Products
- 4.6.5 Intensity of Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUES)

5.1 By Type of Product
- 5.1.1 Chromatographs
- 5.1.1.1 Gas Chromatographs (GC)
- 5.1.1.2 Liquid Chromatographs (HPLC, UHPLC)
- 5.1.1.3 Ion Chromatographs
- 5.1.2 Spectrometer (Mass, Elemental Analysis and Molecular Analysis)
- 5.1.2.1 Mass Spectrometry
- 5.1.2.1.1 LC-MS
- 5.1.2.1.2 GC-MS
- 5.1.2.1.3 MALDI-TOF
- 5.1.2.2 Elemental Analysis
- 5.1.2.2.1 ICP-MS
- 5.1.2.2.2 ICP-OES
- 5.1.2.3 Molecular Analysis
- 5.1.2.3.1 FT-IR
- 5.1.2.3.2 Raman
- 5.1.2.3.3 UV-Vis
- 5.1.3 Gas Analyzer
- 5.1.3.1 Laser-Based Gas Analyzers
- 5.1.3.2 Electrochemical Gas Analyzers
- 5.1.3.3 Photoacoustic Gas Analyzers
- 5.1.4 Liquid Analyzer
- 5.1.4.1 pH/ORP Analyzers
- 5.1.4.2 Dissolved Oxygen (DO) Analyzers
- 5.1.4.3 Conductivity and Total Organic Carbon (TOC) Analyzers
- 5.1.5 Analytical X-ray Instrumentation and Analytical Microscopes
- 5.1.5.1 X-ray Diffraction (XRD)
- 5.1.5.2 X-ray Fluorescence (XRF)
- 5.1.5.3 Electron Microscopes (SEM, TEM)
- 5.1.5.4 Atomic Force Microscopes (AFM)
5.2 By End User Vertical
- 5.2.1 Biopharmaceutical and Nutraceutical
- 5.2.1.1 Biologics Manufacturers
- 5.2.1.2 Nutraceutical Producers
- 5.2.2 Pharmaceutical
- 5.2.2.1 Active Pharmaceutical Ingredient (API) Manufacturers
- 5.2.2.2 Contract Research and Manufacturing Organizations (CROs/CDMOs)
5.3 By Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Nordics
- 5.3.2.5 Rest of Europe
- 5.3.3 South America
- 5.3.3.1 Brazil
- 5.3.3.2 Rest of South America
- 5.3.4 Asia-Pacific
- 5.3.4.1 China
- 5.3.4.2 Japan
- 5.3.4.3 India
- 5.3.4.4 South-East Asia
- 5.3.4.5 Rest of Asia-Pacific
- 5.3.5 Middle East and Africa
- 5.3.5.1 Middle East
- 5.3.5.1.1 Gulf Cooperation Council Countries
- 5.3.5.1.2 Turkey
- 5.3.5.1.3 Rest of Middle East
- 5.3.5.2 Africa
- 5.3.5.2.1 South Africa
- 5.3.5.2.2 Rest of Africa

6. COMPETITIVE LANDSCAPE

6.1 Market Concentration
6.2 Strategic Moves (M&A, Partnerships, Product Launches)
6.3 Market Share Analysis
6.4 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)}
- 6.4.1 Thermo Fisher Scientific Inc.
- 6.4.2 Agilent Technologies Inc.
- 6.4.3 Waters Corporation
- 6.4.4 Shimadzu Corporation
- 6.4.5 Bruker Corporation
- 6.4.6 Danaher Corporation (SCIEX and Pall)
- 6.4.7 PerkinElmer Inc.
- 6.4.8 Mettler Toledo International Inc.
- 6.4.9 Sartorius AG
- 6.4.10 Merck KGaA (MilliporeSigma)
- 6.4.11 Bio-Rad Laboratories Inc.
- 6.4.12 Malvern Panalytical Ltd.
- 6.4.13 Metrohm AG
- 6.4.14 JASCO Corporation
- 6.4.15 JEOL Ltd.
- 6.4.16 LECO Corporation
- 6.4.17 Anton Paar GmbH
- 6.4.18 HORIBA Ltd.
- 6.4.19 Tecan Group Ltd.
- 6.4.20 Hitachi High-Tech Corporation

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

7.1 White-Space and Unmet-Need Assessment
7.2 Emerging Opportunities in Point-of-Need Microfluidic Analyzers
7.3 Integration of Real-Time Release Testing (RTRT)
7.4 Digital Twin and Predictive Maintenance for Analytical Labs

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections

Get Price Break-up Now

Global Analytical Instrumentation In Life Science Market Report Scope

Analytical instrumentation in the life science industry helps analyze the materials, establish the composition, quality control, drug discovery, and research and development. The scope of the study includes the revenue accrued from the sale of various types of analytical instruments for various applications in the life sciences industry. This segment includes industries such as pharmaceuticals and biopharmaceuticals - establishments engaged in manufacturing medicinal and pharmaceutical products.

The analytical instrumentation market in the lifesciences industry is segmented by type of product (chromatographs, spectrometer (mass, elemental analysis, and molecular analysis), gas analyzer, liquid analyzer, and analytical x-ray instrumentation and analytical microscopes), end-user vertical (the biopharmaceutical and nutraceutical, and pharmaceutical) and geography (North America, Europe, Asia-Pacific, Rest of the World). The market sizes and forecasts are provided in terms of value in (USD) for all the above segments.

By Type of Product

Chromatographs	Gas Chromatographs (GC)
	Liquid Chromatographs (HPLC, UHPLC)
	Ion Chromatographs

Spectrometer (Mass, Elemental Analysis and Molecular Analysis)	Mass Spectrometry	LC-MS
		GC-MS
		MALDI-TOF

	Elemental Analysis	ICP-MS
		ICP-OES

	Molecular Analysis	FT-IR
		Raman
		UV-Vis
Gas Analyzer	Laser-Based Gas Analyzers
	Electrochemical Gas Analyzers
	Photoacoustic Gas Analyzers
Liquid Analyzer	pH/ORP Analyzers
	Dissolved Oxygen (DO) Analyzers
	Conductivity and Total Organic Carbon (TOC) Analyzers
Analytical X-ray Instrumentation and Analytical Microscopes	X-ray Diffraction (XRD)
	X-ray Fluorescence (XRF)
	Electron Microscopes (SEM, TEM)
	Atomic Force Microscopes (AFM)

By End User Vertical

Biopharmaceutical and Nutraceutical	Biologics Manufacturers
	Nutraceutical Producers
Pharmaceutical	Active Pharmaceutical Ingredient (API) Manufacturers
	Contract Research and Manufacturing Organizations (CROs/CDMOs)

By Geography

North America	United States
	Canada
	Mexico
Europe	Germany
	United Kingdom
	France
	Nordics
	Rest of Europe
South America	Brazil
	Rest of South America
Asia-Pacific	China
	Japan
	India
	South-East Asia
	Rest of Asia-Pacific

Middle East and Africa	Middle East	Gulf Cooperation Council Countries
		Turkey
		Rest of Middle East

	Africa	South Africa
		Rest of Africa

By Type of Product	Chromatographs	Gas Chromatographs (GC)
		Liquid Chromatographs (HPLC, UHPLC)
		Ion Chromatographs

	Spectrometer (Mass, Elemental Analysis and Molecular Analysis)	Mass Spectrometry	LC-MS
			GC-MS
			MALDI-TOF

		Elemental Analysis	ICP-MS
			ICP-OES

		Molecular Analysis	FT-IR
			Raman
			UV-Vis

	Gas Analyzer	Laser-Based Gas Analyzers
		Electrochemical Gas Analyzers
		Photoacoustic Gas Analyzers

	Liquid Analyzer	pH/ORP Analyzers
		Dissolved Oxygen (DO) Analyzers
		Conductivity and Total Organic Carbon (TOC) Analyzers

	Analytical X-ray Instrumentation and Analytical Microscopes	X-ray Diffraction (XRD)
		X-ray Fluorescence (XRF)
		Electron Microscopes (SEM, TEM)
		Atomic Force Microscopes (AFM)

By End User Vertical	Biopharmaceutical and Nutraceutical	Biologics Manufacturers
		Nutraceutical Producers

	Pharmaceutical	Active Pharmaceutical Ingredient (API) Manufacturers
		Contract Research and Manufacturing Organizations (CROs/CDMOs)

By Geography	North America	United States
		Canada
		Mexico

	Europe	Germany
		United Kingdom
		France
		Nordics
		Rest of Europe

	South America	Brazil
		Rest of South America

	Asia-Pacific	China
		Japan
		India
		South-East Asia
		Rest of Asia-Pacific

	Middle East and Africa	Middle East	Gulf Cooperation Council Countries
			Turkey
			Rest of Middle East

		Africa	South Africa
			Rest of Africa

Need A Different Region or Segment?

Customize Now

Key Questions Answered in the Report

What is the current size of the analytical instrumentation in life science market?

The analytical instrumentation in life science market reached USD 20.45 billion in 2025 and is projected to expand to USD 31.18 billion by 2030.

Which region is growing the fastest?

Asia-Pacific is the fastest-growing region, posting a 9.5% CAGR through 2030 due to expanding CDMO capacity and government incentives.

Which product segment shows the highest growth?

Spectrometers, particularly high-resolution mass-spectrometry platforms, are forecast to grow at an 8.2% CAGR through 2030 as biologics characterization needs intensify.

Who are the leading companies in this market?

Thermo Fisher Scientific leads with 23% revenue share, followed by Agilent Technologies, Waters Corporation, Danaher, and Bruker.

How is regulation influencing instrument demand?

Stricter FDA and EMA guidance on continuous manufacturing and PAT drives real-time analytical adoption, boosting demand for in-line chromatography and mass-spectrometry systems.

What key challenge could slow market growth?

High capital expenditure and a shortage of skilled analytical chemists remain significant barriers, potentially curbing instrument deployment in resource-constrained settings.

Page last updated on: August 29, 2025